3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
NET
1
Myeloid
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Carcinoma, Non-Small-Cell Lung
164
Lung Neoplasms
61
Small Cell Lung Carcinoma
24
Neoplasms
10
NSCLC
9
Mesothelioma, Malignant
9
Breast Neoplasms
8
Pancreatic Neoplasms
7
Ovarian Neoplasms
7
Melanoma
6
Head and Neck Neoplasms
6
Colorectal Neoplasms
6
Esophageal Neoplasms
5
Stomach Neoplasms
4
Neoplasm Metastasis
4
Mesothelioma
4
Kidney Neoplasms
4
Brain Neoplasms
4
Sarcoma
3
Pleural Effusion, Malignant
3
Liver Neoplasms
3
Fallopian Tube Neoplasms
3
Cholangiocarcinoma
3
Carcinoma
3
Adenocarcinoma of Lung
3
Uterine Cervical Neoplasms
2
Thymus Neoplasms
2
Thymoma
2
Small Cell Lung Cancer Limited Stage
2
Skin Neoplasms
2
Interventions
Filgrastim
3
Carboplatin
3
Trastuzumab
2
Taxes
2
Peripheral Blood Stem Cell Transplantation
2
Paclitaxel
2
Cyclophosphamide
2
zenocutuzumab
1
veliparib
1
tislelizumab
1
tipifarnib
1
spartalizumab
1
etoposide phosphate
1
erythromycin propionate-N-acetylcysteinate
1
entinostat
1
atezolizumab
1
Topotecan
1
Surveys and Questionnaires
1
Quality of Life
1
Polymerase Chain Reaction
1
Patient Reported Outcome Measures
1
Molecular Diagnostic Techniques
1
Interleukin-12 Subunit p35
1
Interleukin-12
1
Immunotherapy
1
Immunohistochemistry
1
Ifosfamide
1
Genetic Profile
1
Gene Expression Profiling
1
Gemcitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasms, Unknown Primary
×
Drug Therapy
×
Thoracic
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled